I. Baldi, A. Huchet, L. Bauchet, and H. Loiseau, ??pid??miologie des glioblastomes, Neurochirurgie, vol.56, issue.6, pp.433-473, 2010.
DOI : 10.1016/j.neuchi.2010.07.011

H. Ohgaki and P. Kleihues, Population-Based Studies on Incidence, Survival Rates, and Genetic Alterations in Astrocytic and Oligodendroglial Gliomas, Journal of Neuropathology & Experimental Neurology, vol.10, issue.6, pp.479-89, 2005.
DOI : 10.1093/carcin/16.6.1277

S. Zouaoui, Recensement national histologique des tumeurs primitives du syst??me nerveux central??: r??sultats g??n??raux sur 40??000??cas, principales applications actuelles et perspectives, Neurochirurgie, vol.58, issue.1, pp.4-13, 2012.
DOI : 10.1016/j.neuchi.2012.01.004

URL : https://doi.org/10.1016/j.neuchi.2012.01.004

M. Chatel, M. Frenay, C. Lebrun, V. Bourg, and F. Fauchon, Gliomes de haut grade : astrocytomes anaplasiques et glioblastomes, EMC - Neurologie, vol.2, issue.3, pp.257-278, 2005.
DOI : 10.1016/j.emcn.2004.12.002

C. Lebrun, Turcot syndrome confirmed with molecular analysis, European Journal of Neurology, vol.19, issue.4, pp.470-472, 2007.
DOI : 10.1023/A:1006091608586

D. Hanahan and R. Weinberg, Hallmarks of Cancer: The Next Generation, Cell, vol.144, issue.5, pp.646-74, 2011.
DOI : 10.1016/j.cell.2011.02.013

H. Zheng, p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation, Nature, vol.98, issue.7216, pp.1129-1133, 2008.
DOI : 10.1038/nature07443

URL : http://europepmc.org/articles/pmc4051433?pdf=render

J. Schwartzentruber, Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma, Nature, vol.16, issue.7384, pp.226-257, 2012.
DOI : 10.1101/gr.5402306

D. Conte, Loss of Atrx Sensitizes Cells to DNA Damaging Agents through p53-Mediated Death Pathways, PLoS ONE, vol.93, issue.12, 2012.
DOI : 10.1371/journal.pone.0052167.s002

P. H. Huang, A. M. Xu, and F. M. White, Oncogenic EGFR Signaling Networks in Glioma, Science Signaling, vol.2, issue.87, 2009.
DOI : 10.1126/scisignal.287re6

G. Genovese, microRNA Regulatory Network Inference Identifies miR-34a as a Novel Regulator of TGF-?? Signaling in Glioblastoma, Cancer Discovery, vol.2, issue.8, pp.736-749, 2014.
DOI : 10.1158/2159-8290.CD-12-0111

T. R. Fenton, Resistance to EGF receptor inhibitors in glioblastoma mediated by phosphorylation of the PTEN tumor suppressor at tyrosine 240, Proceedings of the National Academy of Sciences, vol.9, issue.3, pp.1-6, 2012.
DOI : 10.1111/j.1750-3639.1999.tb00536.x

D. Kaneshiro, T. Kobayashi, S. T. Chao, J. Suh, and R. A. Prayson, Chromosome 1p and 19q Deletions in Glioblastoma Multiforme, Applied Immunohistochemistry & Molecular Morphology, vol.17, issue.6, pp.512-518, 2009.
DOI : 10.1097/PAI.0b013e3181a2c6a4

M. Sanson, J. Thillet, and K. Hoang-­?xuan, Molecular changes in gliomas, Current Opinion in Oncology, vol.16, issue.6, pp.607-620, 2004.
DOI : 10.1097/01.cco.0000142485.81849.cc

F. Ducray, Biology of gliomas]. Cancer Radiother, pp.663-671, 2008.

S. Prasad, J. Ravindran, and B. B. , NF-??B and cancer: how intimate is this relationship, Molecular and Cellular Biochemistry, vol.24, issue.1-2, pp.25-37, 2011.
DOI : 10.4049/jimmunol.164.12.6509

URL : http://europepmc.org/articles/pmc3148942?pdf=render

J. D. Lathia, M. P. Mattson, and A. Cheng, Notch: from neural development to neurological disorders, Journal of Neurochemistry, vol.11, issue.6, pp.1471-81, 2008.
DOI : 10.1128/MCB.18.4.2230

M. Kanamori, Contribution of Notch signaling activation to human glioblastoma multiforme, Journal of Neurosurgery, vol.1, issue.3, pp.417-444, 2007.
DOI : 10.2174/1389201003379013

B. W. Purow, Expression of Notch-­?1 and Its Ligands , Delta-­?Like-­?1 and Jagged-­?1 , Is Critical for Glioma Cell Survival and Proliferation Is Critical for Glioma Cell Survival and Proliferation, pp.2353-2363, 2005.

X. Fana, L. Khakic, T. S. Zhua, M. E. Soulesa, C. E. Talsmaa et al., Notch Pathway Blockade Depletes CD133-Positive Glioblastoma Cells and Inhibits Growth of Tumor Neurospheres and Xenografts, Stem Cells, vol.28, pp.5-16, 2010.
DOI : 10.1002/stem.254

W. Wick, U. Naumann, and M. Weller, Transforming Growth Factor-β: A Molecular Target for the Future Therapy of Glioblastoma, Current Pharmaceutical Design, vol.12, issue.3, pp.341-350, 2006.
DOI : 10.2174/138161206775201901

S. G. Piccirillo, Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells, Nature, vol.156, issue.7120, pp.761-766, 2006.
DOI : 10.1006/exnr.1998.6998

W. Zhuang, Induction of autophagy promotes differentiation of glioma-initiating cells and their radiosensitivity, International Journal of Cancer, vol.4, issue.11, pp.2720-2751, 2011.
DOI : 10.4161/auto.5338

Y. Yoshida, K. Takahashi, K. Okita, T. Ichisaka, and S. Yamanaka, Hypoxia Enhances the Generation of Induced Pluripotent Stem Cells, Cell Stem Cell, vol.5, issue.3, pp.237-278, 2009.
DOI : 10.1016/j.stem.2009.08.001

J. Wang, c-Myc Is Required for Maintenance of Glioma Cancer Stem Cells, PLoS ONE, vol.8, issue.11, 2008.
DOI : 10.1371/journal.pone.0003769.g007

M. Abdouh, BMI1 Sustains Human Glioblastoma Multiforme Stem Cell Renewal, Journal of Neuroscience, vol.29, issue.28, pp.8884-96, 2009.
DOI : 10.1523/JNEUROSCI.0968-09.2009

URL : http://www.jneurosci.org/content/jneuro/29/28/8884.full.pdf

A. Conti, miR-21 and 221 upregulation and miR-181b downregulation in human grade II???IV astrocytic tumors, Journal of Neuro-Oncology, vol.1236, issue.3, pp.325-332, 2009.
DOI : 10.4161/cc.6.16.4526

H. Gal, MIR-451 and Imatinib mesylate inhibit tumor growth of Glioblastoma stem cells, Biochemical and Biophysical Research Communications, vol.376, issue.1, pp.86-90, 2008.
DOI : 10.1016/j.bbrc.2008.08.107

J. Silber, miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells, BMC Medicine, vol.6, issue.3, pp.1-17, 2008.
DOI : 10.1158/1535-7163.MCT-06-0691

P. Bertone, Global Identification of Human Transcribed Sequences with Genome Tiling Arrays, Science, vol.306, issue.5705, pp.2242-2248, 2004.
DOI : 10.1126/science.1103388

P. Kapranov, RNA Maps Reveal New RNA Classes and a Possible Function for Pervasive Transcription, Science, vol.4, issue.6, pp.1484-1492, 2007.
DOI : 10.1016/0959-437X(94)90066-3

D. Ramsköld, E. T. Wang, C. B. Burge, and R. Sandberg, An Abundance of Ubiquitously Expressed Genes Revealed by Tissue Transcriptome Sequence Data, PLoS Computational Biology, vol.10, issue.12, 2009.
DOI : 10.1371/journal.pcbi.1000598.s011

J. E. Wilusz, H. Sunwoo, and D. L. Spector, Long noncoding RNAs: functional surprises from the RNA world, Genes & Development, vol.23, issue.13, pp.1494-1504, 2009.
DOI : 10.1101/gad.1800909

T. R. Mercer, M. E. , and J. S. , Long non-coding RNAs: insights into functions, Nature Reviews Genetics, vol.72, issue.3
DOI : 10.1093/oxfordjournals.molbev.a003951

R. Shalgi, R. Brosh, M. Oren, Y. Pilpel, and V. Rotter, Coupling transcriptional and post-transcriptional miRNA regulation in the control of cell fate, Aging, vol.1, issue.9, pp.762-70, 2009.
DOI : 10.18632/aging.100085

A. E. Erson and E. M. Petty, miRNAs and cancer: New research developments and potential clinical applications, Cancer Biology & Therapy, vol.8, issue.24, pp.2317-2339, 2009.
DOI : 10.4161/cbt.8.24.10765

URL : http://www.tandfonline.com/doi/pdf/10.4161/cbt.8.24.10765?needAccess=true

M. Esteller, Non-coding RNAs in human disease, Nature Reviews Genetics, vol.39, issue.12, pp.861-74, 2011.
DOI : 10.1136/jmg.39.12.872

S. Memczak, Circular RNAs are a large class of animal RNAs with regulatory potency, Nature, vol.40, issue.7441, pp.333-341, 2013.
DOI : 10.1093/nar/gkr688

J. L. Munoz, Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell???derived Exosomes to Glioblastoma Multiforme Cells Conferred Chemosensitivity, Molecular Therapy - Nucleic Acids, vol.2, 2013.
DOI : 10.1038/mtna.2013.60

K. Al-­?nedawi, B. Meehan, J. Rak, and . Microvesicles, Microvesicles: Messengers and mediators of tumor progression, Cell Cycle, vol.8, issue.13, pp.2014-2018, 2014.
DOI : 10.4161/cc.8.13.8988

V. Valiunas, Connexin-specific cell-to-cell transfer of short interfering RNA by gap junctions, The Journal of Physiology, vol.11, issue.2, pp.459-68, 2005.
DOI : 10.1038/sj.gt.3302210

M. Fabbri, MicroRNAs bind to Toll-­?like receptors to induce prometastatic in fl ammatory response, Proc. Natl. Acad. Sci, pp.2110-2116, 2012.

J. Wang, K. Sai, F. Chen, and . Chen, miR-181b modulates glioma cell sensitivity to temozolomide by targeting MEK1, Cancer Chemotherapy and Pharmacology, vol.26, issue.Suppl 2, pp.147-58, 2013.
DOI : 10.1038/sj.onc.1210422

B. M. Alrfaei, R. Vemuganti, and J. S. Kuo, microRNA-100 Targets SMRT/NCOR2, Reduces Proliferation, and Improves Survival in Glioblastoma Animal Models, PLoS ONE, vol.9, issue.11, 2013.
DOI : 10.1371/journal.pone.0080865.s004

M. Henriksen, K. B. Johnsen, H. H. Andersen, L. Pilgaard, and M. Duroux, MicroRNA Expression Signatures Determine Prognosis and Survival in Glioblastoma Multiforme???a Systematic Overview, Molecular Neurobiology, vol.18, issue.Suppl 5, 2014.
DOI : 10.1111/j.1755-5949.2012.00344.x

D. Schraivogel, in glioblastoma stem cells, The EMBO Journal, vol.16, issue.20, pp.4309-4331, 2011.
DOI : 10.1038/nsmb.1576

N. Wu, miR-125b regulates the proliferation of glioblastoma stem cells by targeting E2F2, FEBS Letters, vol.35, issue.21, pp.3831-3840, 2012.
DOI : 10.1016/j.molcel.2009.08.020

Y. Wan, Expression of miR-­?125b in the new, highly invasive glima stem cell and progenitor cell line SU3, pp.207-214, 2012.

L. Shi, MiR-125b is critical for the suppression of human U251 glioma stem cell proliferation, Brain Research, vol.1312, pp.120-126, 2010.
DOI : 10.1016/j.brainres.2009.11.056

H. Xia, Loss of Brain-enriched miR-124 MicroRNA Enhances Stem-like Traits and Invasiveness of Glioma Cells, Journal of Biological Chemistry, vol.460, issue.13, pp.9962-71, 2012.
DOI : 10.1101/gad.1519107

J. Mei, R. Bachoo, and C. Zhang, MicroRNA-146a Inhibits Glioma Development by Targeting Notch1, Molecular and Cellular Biology, vol.31, issue.17, pp.3584-92, 2011.
DOI : 10.1128/MCB.05821-11

URL : http://mcb.asm.org/content/31/17/3584.full.pdf

J. Permuth-­?wey, R. C. Thompson, L. B. Nabors, J. J. Olson, and K. M. Egan, A functional polymorphism in the pre-miR-146a gene is associated with risk and prognosis in adult glioma, Journal of Neuro-Oncology, vol.30, issue.12, pp.639-646, 2012.
DOI : 10.1002/humu.20837

A. Tivnan and K. L. Mcdonald, Current Progress for the Use of miRNAs in Glioblastoma Treatment, Molecular Neurobiology, vol.124, issue.17, pp.757-68, 2013.
DOI : 10.1261/rna.036467.112

N. Dias and C. A. Stein, Antisense Oligonucleotides : Basic Concepts and Mechanisms Minireview Antisense Oligonucleotides : Basic Concepts and Mechanisms, Mol. Cancer Ther, vol.1, pp.347-355, 2002.

Y. Lu, A single anti-microRNA antisense oligodeoxyribonucleotide (AMO) targeting multiple microRNAs offers an improved approach for microRNA interference, Nucleic Acids Research, vol.11, issue.3, 2009.
DOI : 10.1002/bip.1972.360110712

K. Gumireddy, Y. Douglas, D. , and X. , Small-Molecule Inhibitors of MicroRNA miR-21 Function, Angewandte Chemie International Edition, vol.32, issue.39, pp.7482-7484, 2012.
DOI : 10.1002/anie.200801555

S. Zhang, L. Chen, E. J. Jung, and G. A. , Targeting MicroRNAs With Small Molecules: From Dream to Reality, Clinical Pharmacology & Therapeutics, vol.87, issue.6, pp.754-758, 2014.
DOI : 10.1016/j.cell.2006.02.037

J. Krol, I. Loedige, and W. Filipowicz, The widespread regulation of microRNA biogenesis, function and decay, Nature Reviews Genetics, vol.36, issue.9, pp.597-610, 2010.
DOI : 10.1038/nrg2843

C. Kudo-­?saito, H. Shirako, T. Takeuchi, and Y. Kawakami, Cancer Metastasis Is Accelerated through Immunosuppression during Snail-Induced EMT of Cancer Cells, Cancer Cell, vol.15, issue.3, pp.195-206, 2009.
DOI : 10.1016/j.ccr.2009.01.023

A. Lujambio, Genetic Unmasking of an Epigenetically Silenced microRNA in Human Cancer Cells, Cancer Research, vol.67, issue.4, pp.1424-1433, 2007.
DOI : 10.1158/0008-5472.CAN-06-4218

S. Melo, Small molecule enoxacin is a cancer-­?speci fi c growth inhibitor that acts by enhancing TAR RNA-­?binding protein 2-­?mediated microRNA processing, Proc. Natl. Acad. Sci, pp.4394-4399, 2011.

N. Kosaka, Neutral Sphingomyelinase 2 (nSMase2)-dependent Exosomal Transfer of Angiogenic MicroRNAs Regulate Cancer Cell Metastasis, Journal of Biological Chemistry, vol.3, issue.15, pp.10849-59, 2013.
DOI : 10.1016/j.cellsig.2009.08.010

Y. Wan, G. Sun, S. Zhang, Z. Wang, and L. Shi, MicroRNA-125b inhibitor sensitizes human primary glioblastoma cells to chemotherapeutic drug temozolomide on invasion, In Vitro Cellular & Developmental Biology - Animal, vol.71, issue.2, pp.599-607, 2013.
DOI : 10.1158/0008-5472.CAN-10-2435

W. Wang, Regulation of epidermal growth factor receptor signaling by plasmid-­?based 387

K. C. Wang and H. Chang, Molecular Mechanisms of Long Noncoding RNAs, Molecular Cell, vol.43, issue.6, pp.904-914, 2012.
DOI : 10.1016/j.molcel.2011.08.018

L. Yang, lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs, Nature, vol.272, issue.7464, pp.598-602, 2014.
DOI : 10.1074/jbc.272.10.6146

J. L. Rinn and H. Chang, Genome Regulation by Long Noncoding RNAs, Annual Review of Biochemistry, vol.81, issue.1, pp.145-66, 2012.
DOI : 10.1146/annurev-biochem-051410-092902

URL : http://europepmc.org/articles/pmc3858397?pdf=render

J. Harrow, GENCODE: The reference human genome annotation for The ENCODE Project, Genome Research, vol.22, issue.9
DOI : 10.1101/gr.135350.111

Y. Bai, X. Dai, A. P. Harrison, and M. Chen, RNA regulatory networks in animals and plants: a long noncoding RNA perspective, Briefings in Functional Genomics, vol.11, issue.11, 2014.
DOI : 10.1186/1471-2229-11-61

E. Gibb, C. J. Brown, and W. L. Lam, The functional role of long non-coding RNA in human carcinomas, Molecular Cancer, vol.10, issue.1, p.38, 2011.
DOI : 10.1002/ijc.21425

V. Moran, R. J. Perera, and A. M. Khalil, Emerging functional and mechanistic paradigms of mammalian long non-coding RNAs, Nucleic Acids Research, vol.77, issue.4, pp.6391-400, 2012.
DOI : 10.1016/j.cell.2011.10.002

Y. Zhou, Activation of p53 by MEG3 Non-coding RNA, Journal of Biological Chemistry, vol.39, issue.34, pp.24731-24773, 2007.
DOI : 10.1073/pnas.96.21.11866

M. Huarte, A Large Intergenic Noncoding RNA Induced by p53 Mediates Global Gene Repression in the p53 Response, Cell, vol.142, issue.3, pp.409-419, 2011.
DOI : 10.1016/j.cell.2010.06.040

E. Yildirim, Xist RNA Is a Potent Suppressor of Hematologic Cancer in Mice, Cell, vol.152, issue.4, pp.727-769, 2013.
DOI : 10.1016/j.cell.2013.01.034

W. T. Powell, A Prader???Willi locus lncRNA cloud modulates diurnal genes and energy expenditure, Human Molecular Genetics, vol.30, issue.21, pp.4318-4346, 2013.
DOI : 10.1093/nar/30.1.207

G. Bochenek, The large non-coding RNA ANRIL, which is associated with atherosclerosis, periodontitis and several forms of cancer, regulates ADIPOR1, VAMP3 and C11ORF10, Human Molecular Genetics, vol.21, issue.22, pp.4516-4543, 2013.
DOI : 10.1093/bioinformatics/bth457

K. L. Yap, Molecular Interplay of the Noncoding RNA ANRIL and Methylated Histone H3 Lysine 27 by Polycomb CBX7 in Transcriptional Silencing of INK4a, Molecular Cell, vol.38, issue.5, pp.662-674, 2011.
DOI : 10.1016/j.molcel.2010.03.021

N. Lin, An Evolutionarily Conserved Long Noncoding RNA TUNA Controls Pluripotency and Neural Lineage Commitment, Molecular Cell, vol.53, issue.6, pp.1005-1024, 2014.
DOI : 10.1016/j.molcel.2014.01.021

URL : https://doi.org/10.1016/j.molcel.2014.03.013

Y. W. Yang, Author response, eLife, vol.40, 2014.
DOI : 10.7554/eLife.02046.013

Y. Wang, Endogenous miRNA Sponge lincRNA-RoR Regulates Oct4, Nanog, and Sox2 in Human Embryonic Stem Cell Self-Renewal, Developmental Cell, vol.25, issue.1, pp.69-80, 2013.
DOI : 10.1016/j.devcel.2013.03.002

X. Zhou, Linc-RNA-RoR acts as a ???sponge??? against mediation of the differentiation of endometrial cancer stem cells by microRNA-145, Gynecologic Oncology, vol.133, issue.2, pp.333-342, 2014.
DOI : 10.1016/j.ygyno.2014.02.033

A. Keniry, D. Oxley, P. Monnier, M. Kyba, and L. Dandolo, The H19 lincRNA is a developmental reservoir of miR-675 that suppresses growth and Igf1r, Nature Cell Biology, vol.419, issue.7, pp.659-665, 2013.
DOI : 10.1007/978-1-59745-033-1_6

C. H. Li and Y. Chen, Targeting long non-coding RNAs in cancers: Progress and prospects, The International Journal of Biochemistry & Cell Biology, vol.45, issue.8
DOI : 10.1016/j.biocel.2013.05.030

E. Emadi-­?andani, P. Nikpour, M. Emadi-­?baygi, and A. Bidmeshkipour, Association of HOTAIR expression in gastric carcinoma with invasion and distant metastasis, Adv. Biomed. Res, vol.3, p.135, 2014.

N. K. Lee, Long non-coding RNA HOTAIR promotes carcinogenesis and invasion of gastric adenocarcinoma, Biochemical and Biophysical Research Communications, vol.451, issue.2, pp.171-178, 2014.
DOI : 10.1016/j.bbrc.2014.07.067

W. Zhao, Y. An, Y. Liang, and X. Xie, Role of HOTAIR long noncoding RNA in metastatic progression of lung cancer, Eur. Rev. Med. Pharmacol. Sci, vol.18, pp.1930-1936, 2014.

S. Baritaki, YY1 Over-Expression in Human Brain Gliomas and Meningiomas Correlates with TGF-??1, IGF-1 and FGF-2 mRNA Levels, Cancer Investigation, vol.6, issue.2, pp.184-92, 2009.
DOI : 10.1158/1535-7163.MCT-06-0521

K. Tano and N. Akimitsu, Long non-coding RNAs in cancer progression, Frontiers in Genetics, vol.3, p.219, 2012.
DOI : 10.3389/fgene.2012.00219

W. Yu, Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA, Nature, vol.290, issue.7175, pp.202-206, 2009.
DOI : 10.1128/MCB.17.5.2458

F. Aguilo, M. Zhou, and M. J. , Long Noncoding RNA, Polycomb, and the Ghosts Haunting INK4b-ARF-INK4a Expression, Cancer Research, vol.71, issue.16, pp.5365-5369, 2012.
DOI : 10.1158/0008-5472.CAN-10-4379

G. Wan, R. Mathur, X. Hu, Y. Liu, X. Zhang et al., Long non-coding RNA ANRIL (CDKN2B-AS) is induced by the ATM-E2F1 signaling pathway, Cellular Signalling, vol.25, issue.5, pp.1086-1095, 2014.
DOI : 10.1016/j.cellsig.2013.02.006

K. Lu, Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression, BMC Cancer, vol.137, issue.3, p.461, 2013.
DOI : 10.1016/j.cell.2009.04.037

C. Ernst and C. C. Morton, Identification and function of long non-coding RNA, Frontiers in Cellular Neuroscience, vol.7, p.168, 2013.
DOI : 10.3389/fncel.2013.00168

C. N. Niland, C. R. Merry, and A. M. Khalil, Emerging Roles for Long Non-Coding RNAs in Cancer and Neurological Disorders, Frontiers in Genetics, vol.3, p.25, 2012.
DOI : 10.3389/fgene.2012.00025

B. Zhou, D. R. Beidler, Y. Cheng, and I. Pseudogene, Identification of Antisense RNA Transcripts from a Human DNA Topoisomerase I Pseudogene, Cancer Res, vol.52, pp.4280-4285, 1992.

S. Kalyana-­?sundaram, Expressed Pseudogenes in the Transcriptional Landscape of Human Cancers, Cell, vol.149, issue.7, pp.1622-1634, 2013.
DOI : 10.1016/j.cell.2012.04.041

S. Valadkhan and L. S. Gunawardane, Role of small nuclear RNAs in eukaryotic gene expression, Essays In Biochemistry, vol.9, pp.79-90, 2013.
DOI : 10.1073/pnas.1200523109

J. Karijolich and Y. Yu, Spliceosomal snRNA modifications and their function, RNA Biology, vol.7, issue.2, pp.192-204, 2010.
DOI : 10.4161/rna.7.2.11207

URL : http://www.tandfonline.com/doi/pdf/10.4161/rna.7.2.11207?needAccess=true

M. Koga, U2 snRNP Is Required for Expression of the 3??? End of Genes, PLoS ONE, vol.101, issue.5, p.98015, 2014.
DOI : 10.1371/journal.pone.0098015.s011

O. Reilly and D. , Human snRNA genes use polyadenylation factors to promote efficient transcription termination, Nucleic Acids Res, vol.42, pp.264-75, 2014.

L. E. Maquat and G. G. Carmichael, Quality Control of mRNA Function, Cell, vol.104, issue.2, pp.173-179, 2001.
DOI : 10.1016/S0092-8674(01)00202-1

R. J. Van-alphen, E. Wiemer, C. Burger, H. Eskens, F. et al., The spliceosome as target for anticancer treatment, British Journal of Cancer, vol.30, issue.2, pp.228-260, 2009.
DOI : 10.1038/nature01031

A. J. Ward and T. A. Cooper, The pathobiology of splicing, The Journal of Pathology, vol.325, pp.152-163, 2011.
DOI : 10.1016/S1525-1578(10)60533-8

M. Ladomery, Aberrant Alternative Splicing Is Another Hallmark of Cancer, International Journal of Cell Biology, vol.18, issue.6, p.463786, 2013.
DOI : 10.1016/j.canlet.2012.11.010

S. Bonomi, Oncogenic Alternative Splicing Switches: Role in Cancer Progression and Prospects for Therapy, International Journal of Cell Biology, vol.155, issue.6, p.962038, 2013.
DOI : 10.1158/1078-0432.CCR-10-1932

G. Biamonti, S. Bonomi, S. Gallo, and C. Ghigna, Making alternative splicing decisions during epithelial-to-mesenchymal transition (EMT), Cellular and Molecular Life Sciences, vol.9, issue.15, pp.2515-2541, 2012.
DOI : 10.1038/nrm2525

C. Ghigna, Pro-­?metastatic splicing of Ron proto-­?oncogene mRNA can be reversed: Therapeutic potential of bifunctional oligonucleotides and indole derivatives Pro-­?metastatic splicing of Ron proto-­?oncogene mRNA can be reversed, pp.495-503, 2010.

L. H. Boise, bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death, Cell, vol.74, issue.4, pp.597-608, 1993.
DOI : 10.1016/0092-8674(93)90508-N

R. Pio and L. M. Montuenga, Alternative Splicing in Lung Cancer, Journal of Thoracic Oncology, vol.4, issue.6, pp.674-682, 2009.
DOI : 10.1097/JTO.0b013e3181a520dc

J. Cheng, Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule, Science, vol.263, issue.5154, pp.1759-62, 1994.
DOI : 10.1126/science.7510905

L. Xu, FASL rs763110 polymorphism contributes to cancer risk: an updated meta-­?analysis involving 43,295 subjects, PLoS One, vol.8, 2013.

E. Thurner, Zusammenhang zwischen Polymorphismen in den Apoptosegenen FAS und FASL mit strahleninduzierter Sp??ttoxizit??t nach Radiotherapie des Prostatakarzinoms, Strahlentherapie und Onkologie, vol.8, issue.3, pp.304-313, 2014.
DOI : 10.2741/927

B. De-craene and G. Berx, Regulatory networks defining EMT during cancer initiation and progression, Nature Reviews Cancer, vol.1611, issue.2, pp.97-110, 2013.
DOI : 10.1016/S0005-2736(03)00048-8

D. Meulder and B. , Meta-Analysis and Gene Set Analysis of Archived Microarrays Suggest Implication of the Spliceosome in Metastatic and Hypoxic Phenotypes, PLoS ONE, vol.66, issue.1, p.86699, 2014.
DOI : 10.1371/journal.pone.0086699.s006

H. R. Christofk, The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth, Nature, vol.3, issue.7184, pp.230-233, 2008.
DOI : 10.1038/nature06734

A. R. Morris, Alternative Cleavage and Polyadenylation during Colorectal Cancer Development, Clinical Cancer Research, vol.18, issue.19, pp.5256-66, 2012.
DOI : 10.1158/1078-0432.CCR-12-0543

URL : http://clincancerres.aacrjournals.org/content/clincanres/18/19/5256.full.pdf

S. Vorlová, Induction of Antagonistic Soluble Decoy Receptor Tyrosine Kinases by Intronic PolyA Activation, Molecular Cell, vol.43, issue.6, pp.927-939, 2013.
DOI : 10.1016/j.molcel.2011.08.009

L. Spraggon and L. Cartegni, Antisense modulation of RNA processing as a therapeutic approach in cancer therapy, Drug Discovery Today: Therapeutic Strategies, vol.10, issue.3, 2013.
DOI : 10.1016/j.ddstr.2013.06.002

U. Weirauch, A. Grünweller, L. Cuellar, R. K. Hartmann, and A. Aigner, U1 Adaptors for the Therapeutic Knockdown of the Oncogene Pim-1 Kinase in Glioblastoma, Nucleic Acid Therapeutics, vol.23, issue.4, pp.264-72, 2013.
DOI : 10.1089/nat.2012.0407

B. Pilch, Specific Inhibition of Serine-­? and Arginine-­?rich Splicing Factors Phosphorylation , Spliceosome Assembly , and Splicing by the Antitumor Drug NB-­?506 Specific Inhibition of Serine-­? and Arginine-­?rich Splicing Factors Phosphorylation , Spliceosome Assembly, Cancer Res, vol.61, pp.6876-6884, 2001.

A. Wotawa, S. Solier, E. Logette, E. Solary, and L. Corcos, Differential influence of etoposide on two caspase-2 mRNA isoforms in leukemic cells, Cancer Letters, vol.185, issue.2, pp.181-190, 2002.
DOI : 10.1016/S0304-3835(02)00287-2

S. Solier and A. Lansiaux, Emmanuelle Logette, et al. Topoisomerase I and II Inhibitors Control Caspase-­?2 Pre-­?Messenger RNA Splicing

L. Salmena, L. Poliseno, Y. Tay, L. Kats, and P. P. Pandolfi, A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?, Cell, vol.146, issue.3, pp.353-358, 2012.
DOI : 10.1016/j.cell.2011.07.014

J. L. Franklin, Malignant transformation of colonic epithelial cells by a colon-derived long noncoding RNA, Biochemical and Biophysical Research Communications, vol.440, issue.1, pp.99-104, 2013.
DOI : 10.1016/j.bbrc.2013.09.040

J. Liz, Regulation of pri-miRNA Processing by a Long Noncoding RNA Transcribed from an Ultraconserved Region, Molecular Cell, vol.55, issue.1, pp.138-185, 2014.
DOI : 10.1016/j.molcel.2014.05.005

B. S. Plosky, An Ultraconserved lnc to miRNA Processing, Molecular Cell, vol.55, issue.1, pp.3-4, 2014.
DOI : 10.1016/j.molcel.2014.06.023

URL : https://doi.org/10.1016/j.molcel.2014.06.023

L. Verduci, MicroRNA (miRNA)-mediated Interaction between Leukemia/Lymphoma-related Factor (LRF) and Alternative Splicing Factor/Splicing Factor 2 (ASF/SF2) Affects Mouse Embryonic Fibroblast Senescence and Apoptosis, Journal of Biological Chemistry, vol.269, issue.50, pp.39551-63, 2010.
DOI : 10.1016/j.devcel.2009.09.005

URL : http://www.jbc.org/content/285/50/39551.full.pdf

S. Meseguer, G. Mudduluru, J. M. Escamilla, H. Allgayer, and D. Barettino, MicroRNAs-10a and -10b Contribute to Retinoic Acid-induced Differentiation of Neuroblastoma Cells and Target the Alternative Splicing Regulatory Factor SFRS1 (SF2/ASF), Journal of Biological Chemistry, vol.20, issue.6, pp.4150-64, 2011.
DOI : 10.1016/j.molcel.2007.07.015

O. Kelemen, Function of alternative splicing, Gene, vol.514, issue.1, pp.1-30, 2013.
DOI : 10.1016/j.gene.2012.07.083

V. Tripathi, The Nuclear-Retained Noncoding RNA MALAT1 Regulates Alternative Splicing by Modulating SR Splicing Factor Phosphorylation, Molecular Cell, vol.39, issue.6, pp.925-938, 2014.
DOI : 10.1016/j.molcel.2010.08.011

F. Bardou, Long Noncoding RNA Modulates Alternative Splicing Regulators in Arabidopsis, Developmental Cell, vol.30, issue.2, pp.166-176, 2014.
DOI : 10.1016/j.devcel.2014.06.017

K. S. Rajan and S. Ramasamy, Retrotransposons and piRNA: The missing link in central nervous system, Neurochemistry International, vol.77, 2014.
DOI : 10.1016/j.neuint.2014.05.017

A. Sarkar, R. K. Maji, S. Saha, and Z. Ghosh, piRNAQuest: searching the piRNAome for silencers, BMC Genomics, vol.15, issue.1, p.555, 2014.
DOI : 10.1186/1471-2164-15-555

R. J. Ross, M. M. Weiner, and H. Lin, PIWI proteins and PIWI-interacting RNAs in the soma, Nature, vol.137, issue.7483, pp.353-362, 2014.
DOI : 10.1016/j.cell.2009.04.027

Y. Abel, G. Clerget, V. Bourguignon-­?igel, and V. Salone, Les petits ARN nucl??olaires nous surprennent encore??!, m??decine/sciences, vol.25, issue.3, pp.297-302, 2014.
DOI : 10.1051/medsci/2009255505

URL : http://www.medecinesciences.org/articles/medsci/pdf/2014/03/medsci20143003p297.pdf

G. Matera, R. M. Terns, and M. P. Terns, Non-coding RNAs: lessons from the small nuclear and small nucleolar RNAs, Nature Reviews Molecular Cell Biology, vol.18, issue.3, pp.209-229, 2007.
DOI : 10.1128/MCB.18.12.7106

K. Mannoor, J. Shen, J. Liao, Z. Liu, and F. Jiang, Small nucleolar RNA signatures of lung tumor-initiating cells, Molecular Cancer, vol.13, issue.1, p.104, 2014.
DOI : 10.1016/j.stem.2011.10.008

J. T. Huse and K. D. Aldape, The molecular landscape of diffuse glioma and prospects for biomarker development, Expert Opinion on Medical Diagnostics, vol.18, issue.3, pp.573-87, 2013.
DOI : 10.1093/jnci/88.20.1456

H. Su, Elevated snoRNA biogenesis is essential in breast cancer, Oncogene, vol.7, issue.11, pp.1348-58, 2014.
DOI : 10.1158/0008-5472.CAN-08-2886